Replies to post #115280 on Biotech Values

[pcrutch]

Most people had been touting $60+ and Piper even chimed out $72. I dont think $45-50 was sky high expectations. I might have been overly optimistic, but certainly not as much so as most.

I learned my lesson. It basically took back a good chunk of what I made off of approval. At least my source was right about them being acquired, but they totally missed the boat on the buyer.